Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis
Authors:
- Gerhard OpelzGOGerhard Opelz
- Volker DanielVDVolker Daniel
- Cord NaujokatCNCord Naujokat
- Helmut FickenscherHFHelmut Fickenscher
- Bernd DöhlerBDBernd Döhler
- 1 March 2007
- journal article
- research article
- Published by Elsevier in The Lancet Oncology
- Vol. 8 (3) , 212-218
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- A Mouse Monoclonal Antibody against Epstein‐Barr Virus Envelope Glycoprotein 350 Prevents Infection Both In Vitro and In VivoThe Journal of Infectious Diseases, 2006
- Ganciclovir and Acyclovir Reduce the Risk of Post‐Transplant Lymphoproliferative Disorder in Renal Transplant RecipientsAmerican Journal of Transplantation, 2005
- Herpesvirus Infections in Solid Organ Transplant Patients at High Risk of Primary Cytomegalovirus DiseaseThe Journal of Infectious Diseases, 2005
- Differences between Early and Late Posttransplant Lymphoproliferative Disorders in Solid Organ Transplant Patients: Are They Two Different Diseases?Transplantation, 2005
- Anti-viral prophylaxis reduces the incidence of lymphoproliferative disease in lung transplant recipientsThe Journal of Heart and Lung Transplantation, 2002
- Epstein‐Barr Virus Gene Expression in the Peripheral Blood of Transplant Recipients with Persistent Circulating Virus LoadsThe Journal of Infectious Diseases, 2000
- The role of EBV in post-transplant malignancies: a reviewJournal of Clinical Pathology, 2000
- PREVENTION AND PREEMPTIVE THERAPY OF POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE IN PEDIATRIC LIVER RECIPIENTS1Transplantation, 1998
- Incidence of non-hodgkin lymphoma in kidney and heart transplant recipientsThe Lancet, 1993
- Gamma‐globulin modulates growth of EBV‐derived B‐cell tumors in scid mice reconstituted with human lymphocytesInternational Journal of Cancer, 1993